Showing results (1461-1470 of 1,524) with videos related to

Sort By:
Pageof 153
Nature Communications|May 6, 2015
Two susceptibility loci identified for prostate cancer aggressivenessSonja I Berndt, Zhaoming Wang, Meredith Yeager, et al.
BMJ (Clinical Research Ed.)|January 5, 2019
Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort ConsortiumDavid C Muller, Tricia L Larose, Allison Hodge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2019
Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3)H Zuo, P M Ueland, Ø Midttun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3)D C Muller, A M Hodge, A Fanidi, et al.
International Journal of Epidemiology|August 31, 2012
Association between adult height, genetic susceptibility and risk of gliomaCari M Kitahara, Sophia S Wang, Beatrice S Melin, et al.
International Journal of Cancer|December 15, 2017
Impaired functional vitamin B6 status is associated with increased risk of lung cancerDespoina Theofylaktopoulou, Øivind Midttun, Per M Ueland, et al.
International Journal of Epidemiology|June 15, 2018
Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)Tricia L Larose, Florence Guida, Anouar Fanidi, et al.
The American Journal of Clinical Nutrition|April 21, 2017
Circulating concentrations of biomarkers and metabolites related to vitamin status, one-carbon and the kynurenine pathways in US, Nordic, Asian, and Australian populationsØivind Midttun, Despoina Theofylaktopoulou, Adrian McCann, et al.
International Journal of Cancer|July 6, 2019
Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)Joyce Y Huang, Tricia L Larose, Hung N Luu, et al.
Annals of Epidemiology|November 21, 2022
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) ProgramHilary A Robbins, Karine Alcala, Elham Khodayari Moez, et al.
Pageof 153